(Q36380430)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Personalized approach of medication by indirect anticoagulants tailored to the patient-Russian context: what are the prospects? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

Natalia Viktorovna Kokh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Liliya Alexandrovna Belozerceva

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Elena Nikolaevna Voronina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Galina Alexandrovna Tsvetovskay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Andrei Pavlovich Momot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Galina Israilevna Lifshits

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Maxim Leonidovich Filipenko

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Andrei Ivanovich Shevela

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Valentin Viktorovich Vlasov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

27 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

9 March 2020

start time

27 September 2012

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

A Japanese health success story: trends in cardiovascular diseases, their risk factors, and the contribution of public health and personalized approaches

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

The future of warfarin pharmacogenetics in under-represented minority groups

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Warfarin sensitivity genotyping: a review of the literature and summary of patient experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

The largest prospective warfarin-treated cohort supports genetic forecasting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

CYP4F2 genetic variant alters required warfarin dose

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Association of warfarin dose with genes involved in its action and metabolism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

The pharmocogenomics of warfarin: closing in on personalized medicine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Pharmacogenomics: from bedside to clinical practice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Identification of the gene for vitamin K epoxide reductase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Pharmacogenetics: potential for individualized drug therapy through genetics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort.

28 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and gamma-glutamyl carboxylase) gene variants with warfarin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Gamma-glutamyl carboxylase and its influence on warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

The human factor VII gene is polymorphic due to variation in repeat copy number in a minisatellite

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Warfarin dose related to apolipoprotein E (APOE) genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Apolipoprotein E (APOE) and warfarin dosing in an Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1878-5085-3-10

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

A molecular mechanism for genetic warfarin resistance in the rat.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492156

Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7)

21 September 2018

1 reference

12 December 2020

Molecular analysis of Polish patients with factor VII deficiency

1 reference

12 December 2020

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis

1 reference

12 December 2020

Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin

1 reference

12 December 2020

The influence of sequence variations in factor VII, gamma-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement

1 reference

12 December 2020

Gamma-glutamyl carboxylase (GGCX) tagSNPs have limited utility for predicting warfarin maintenance dose

1 reference

12 December 2020

Identifiers

DOI

10.1186/1878-5085-3-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 March 2020

1006054747

0 references

Fatcat ID

release_icqhpphrsfeefmwrhrxag7vqde

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/icqhpphrsfeefmwrhrxag7vqde

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PubMed publication ID

23016735

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23016735%20AND%20SRC:MED&resulttype=core&format=json